These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 9674823)
1. Early morning dystonia in Parkinson's disease. Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823 [TBL] [Abstract][Full Text] [Related]
2. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065 [TBL] [Abstract][Full Text] [Related]
3. Severe off-period facial dystonia in Parkinson's disease. Miranda M; Chaná P Mov Disord; 2000 Jan; 15(1):163-4. PubMed ID: 10634259 [No Abstract] [Full Text] [Related]
4. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Zimmerman TR; Sage JI; Lang AE; Mark MH Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678 [TBL] [Abstract][Full Text] [Related]
5. [Levodopa-induced dyskinesia in 176 patients with Parkinson's disease]. Rocha MS; Andrade LA; Ferraz HB; Borges V Arq Neuropsiquiatr; 1995 Dec; 53(4):737-42. PubMed ID: 8729765 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study. Durif F; Devaux I; Pere JJ; Delumeau JC; Bourdeix I; Eur Neurol; 2001; 45(2):111-8. PubMed ID: 11244274 [TBL] [Abstract][Full Text] [Related]
7. Low-dose levodopa therapy in Japanese patients with Parkinson's disease: a retrospective study. Kitagawa M; Tashiro K Intern Med; 2005 Sep; 44(9):939-43. PubMed ID: 16258207 [TBL] [Abstract][Full Text] [Related]
8. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. Melamed E Arch Neurol; 1979 May; 36(5):308-10. PubMed ID: 444100 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
11. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study. Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL; CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687 [TBL] [Abstract][Full Text] [Related]
12. Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. Block G; Liss C; Reines S; Irr J; Nibbelink D Eur Neurol; 1997; 37(1):23-7. PubMed ID: 9018028 [TBL] [Abstract][Full Text] [Related]
13. Square-wave action dystonia in Parkinson's disease. van den Munckhof P; Lenz FA; Chase TN Mov Disord; 1998 Mar; 13(2):354-6. PubMed ID: 9539355 [No Abstract] [Full Text] [Related]
14. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial. Waters CH; Nausieda P; Dzyak L; Spiegel J; Rudzinska M; Silver DE; Tsurkalenko ES; Kell S; Hsu A; Khanna S; Gupta S CNS Drugs; 2015 Apr; 29(4):341-50. PubMed ID: 25895021 [TBL] [Abstract][Full Text] [Related]
15. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
16. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice. Ceballos-Baumann A; Häck HJ Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400 [TBL] [Abstract][Full Text] [Related]
17. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease. Onofrj M; Paci C; Thomas A J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):605-6. PubMed ID: 9771801 [No Abstract] [Full Text] [Related]
18. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Rascol O; Brooks DJ; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E; Lancet; 2005 Mar 12-18; 365(9463):947-54. PubMed ID: 15766996 [TBL] [Abstract][Full Text] [Related]
19. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study]. Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087 [TBL] [Abstract][Full Text] [Related]